By putting patients first and by developing important medicines to help humanity, Jeff Aronin, chairman and CEO of Paragon Biosciences, is a deserving recipient of the Weizmann Institute leadership award.
Jeff Aronin’s work in the pharmaceutical industry has helped thousands live better lives. His singular focus on patients has attracted other leaders to join him at his company, Paragon Biosciences, and Paragon’s portfolio companies, among other businesses that he has started.
One quote defines his commitment to entrepreneurship and innovation in healthcare: “problems people have deemed unsolvable are problems worth solving.” Aronin and his team at Paragon Biosciences live this every day by focusing on healthcare challenges that others may have missed or avoided altogether. By developing novel treatments for unmet medical needs, Aronin and the team at Paragon are living up to the ideals of the Weizmann Institute, a global leader in advancing science and medicine.
Part of leadership means inspiring the next generation of biotech entrepreneurs, That is one important reason behind Jeff Aronin’s decision to found MATTER, a healthcare incubator based in Chicago. More than 200 companies at MATTER are in various stages of development, but all of them are committed to improving healthcare (Alivenewspaper).
As Aronin and his team create innovative biotech startups, they also are helping others do the same — the very essence of what the Weizmann Institute is all about.